Bayview Pharmacy is pleased to present a specially compounded topical gel formulation of Mupirocin 5%/Vancomycin 5%. This unique blend of two potent antibiotics is designed to combat a wide range of skin infections, including impetigo, folliculitis, and other bacterial skin conditions. The Mupirocin component of the gel is particularly effective against gram-positive bacteria, while the Vancomycin component targets gram-negative bacteria. This dual-action antibiotic coverage provides a comprehensive treatment solution for various skin infections.

The Mupirocin/Vancomycin topical gel is a semisolid formulation dispensed through a pump mechanism, facilitating easy and precise application on the skin. This delivery method ensures targeted treatment or absorption of active ingredients in a gel-like consistency. The gel can be applied up to three times daily, depending on the severity of the infection and the advice of your healthcare provider.

It is crucial to note that this formulation should not be used on open wounds or on the face. Furthermore, it should not be used for more than seven days without consulting a healthcare provider. Overuse or misuse of antibiotics can lead to antibiotic resistance, which can make future infections harder to treat.

This Mupirocin/Vancomycin topical gel is a powerful tool in the treatment of a variety of skin infections. However, it is essential to follow the directions provided by your healthcare provider closely. If you have any questions or concerns about this formulation, or if you experience any side effects, please contact your healthcare provider immediately. For any additional questions about this formulation, feel free to reach out to us at Bayview Pharmacy.

Mupirocin 5%/Vancomycin 5% Topical Gel is a semisolid formulation designed for the treatment of mild to moderate skin infections caused by susceptible bacteria. These infections may include impetigo, folliculitis, and furunculosis. The gel is also effective in treating skin and soft tissue infections caused by methicillin-resistant Staphylococcus aureus (MRSA).

The unique combination of mupirocin and vancomycin in this formulation provides a synergistic effect, enhancing the effectiveness of the treatment. The gel is dispensed through a pump mechanism, which facilitates easy and precise application on the skin, ensuring targeted treatment or absorption of the active ingredients.

Patients are advised to apply a thin layer of the gel to the affected area twice daily, or as directed by their healthcare provider. It is crucial to wash hands before and after application to prevent the spread of infection. The treated area should not be covered with a bandage or other dressing unless specifically instructed by a healthcare provider. The product should not be used for longer than 10 days unless directed by a healthcare provider.

Patients should contact their healthcare provider if their symptoms do not improve or if they experience any adverse reactions. Common side effects of Mupirocin 5%/Vancomycin 5% Topical Gel include burning, stinging, itching, redness, and dryness at the application site. If you have any questions about the use of Mupirocin 5%/Vancomycin 5% Topical Gel, please consult your healthcare provider.

Mupirocin 5%/Vancomycin 5% Topical Gel is a potent compounded formulation designed to combat bacterial skin infections. This dual-antibiotic medication combines the power of mupirocin and vancomycin, two antibiotics that work synergistically to eliminate the bacteria causing the infection.

Mupirocin operates by inhibiting the bacteria's ability to produce proteins, a crucial process for their survival and proliferation. On the other hand, vancomycin disrupts the formation of bacterial cell walls, another vital component for their survival and growth. The combined action of these two antibiotics effectively eradicates the bacteria causing the infection.

This topical gel is primarily used to treat bacterial skin infections such as impetigo, folliculitis, and furunculosis. It is designed for direct application to the affected skin area, typically two to three times daily. Adherence to the prescribed treatment regimen is crucial, even if symptoms appear to improve, to ensure complete eradication of the infection.

While Mupirocin 5%/Vancomycin 5% Topical Gel is generally well-tolerated, some individuals may experience side effects such as skin irritation, redness, itching, or burning. In the event of these side effects, it is crucial to consult with your healthcare provider for advice and possible adjustments to the treatment plan.

For any queries or concerns regarding Mupirocin 5%/Vancomycin 5% Topical Gel, or its mechanism of action, please feel free to contact us at Bayview Pharmacy. Our team is committed to providing you with the necessary information and guidance to ensure effective treatment of your skin infection.

This compounded formulation of Mupirocin 5%/Vancomycin 5% Topical Gel is a semisolid preparation that is dispensed through a pump mechanism. This design allows for easy and precise application on the skin, ensuring targeted treatment or absorption of the active ingredients. The gel-like consistency of the formulation aids in its smooth application and absorption into the skin.

It has been effectively used in the treatment of various skin infections such as Impetigo, Folliculitis, Cellulitis, Erysipelas, and Furunculosis. However, it is crucial to note that this formulation is not recommended for use on mucous membranes or open wounds. It is also not suitable for the treatment of systemic infections.

The recommended usage is to apply this formulation to the affected area twice daily for a duration of up to 10 days. It is advised not to use this formulation for more than 10 days as it may lead to the development of resistant bacteria. Post-application, patients should wash their hands thoroughly and avoid contact with the eyes, nose, and mouth.

If any irritation or redness occurs post-application, it is recommended to discontinue use and immediately contact a healthcare provider. This formulation is designed to provide targeted treatment, and any adverse reactions should be promptly addressed to ensure patient safety and efficacy of treatment.